RPS6KA1 and ovarian cancer: We observed a significant decrease in p90RSK phosphorylation upon MAP3K8 inhibition in the two ovarian cancer cell lines tested (Fig. 3e,f; for the original blots, please see Supplementary Fig. 8B).